Organization: Dundee Securities Corp

YM Biosciences concludes $23-million financing

YM Biosciences Inc has concluded a bought financing deal for gross proceeds of $23 million. The Mississauga ON-based firm will receive the financing from a syndicate led by Dundee Securities Corp and including Canaccord Capital Corp, Dlouhy Merchant Group and Haywood Securities. The proceeds will be used primarily to finance pivotal Phase III clinical trials…